---
title: "DAJIAWEIKANG: Termination of the issuance of stocks to specific objects"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/234389298.md"
description: "DAJIAWEIKANG announced that the company held the 13th meeting of the 4th Board of Directors and the 10th meeting of the 4th Supervisory Board on April 3, 2025, and approved the proposal on \"Terminating the Issuance of Stocks to Specific Objects and Withdrawing the Application Documents,\" agreeing to terminate the current issuance of stocks to specific objects and withdraw the application documents"
datetime: "2025-04-03T10:28:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/234389298.md)
  - [en](https://longbridge.com/en/news/234389298.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/234389298.md)
generator: "portal-rs"
---

# DAJIAWEIKANG: Termination of the issuance of stocks to specific objects

According to Jin10 Data on April 3rd, DAJIAWEIKANG announced that the company held the 13th meeting of the fourth board of directors and the 10th meeting of the fourth supervisory board on April 3, 2025, and approved the proposal on terminating the issuance of shares to specific objects and withdrawing the application documents, agreeing to terminate the issuance of shares to specific objects and withdraw the application documents

### Related Stocks

- [301126.CN](https://longbridge.com/en/quote/301126.CN.md)

## Related News & Research

- [REG - Frontier Developmnts - Notice of FY26 Financial Results](https://longbridge.com/en/news/297272100.md)
- [Endovia Health opens FDA INAD file for CannEpil veterinary program](https://longbridge.com/en/news/296915045.md)
- [RCS - Vivo Energy Limited - Notice of Meeting – 2026 Interim Results](https://longbridge.com/en/news/297161642.md)
- [CSPC says FDA clears RSV vaccine candidate SYS 6057 for US clinical trial](https://longbridge.com/en/news/296903628.md)
- [FDA allows marketing of Juul's new e-cigarettes and flavored pods](https://longbridge.com/en/news/297362439.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**